A Phase I, Double-Blind, Multiple-Dose Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between IDX320 and IDX184 in Healthy Subjects.

Trial Profile

A Phase I, Double-Blind, Multiple-Dose Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between IDX320 and IDX184 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Aug 2012

At a glance

  • Drugs IDX 184 (Primary) ; IDX 320 (Primary)
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Aug 2012 The US FDA has placed a partial clinical hold on IDX 184, according to a Idenix Pharmaceuticals media release.
    • 07 Sep 2010 Full data will be presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) 2010, according to an Idenix media release.
    • 07 Sep 2010 Status changed from recruiting to completed, according to an Idenix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top